A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer.

Collins, R; Fenwick, E; Trowman, R; Perard, R; Norman, G; Light, K; Birtle, A; Palmer, S; Riemsma, R

Collins, R; Fenwick, E; Trowman, R; Perard, R; Norman, G; Light, K; Birtle, A; Palmer, S; Riemsma, R.

Affiliation

Collins R; Centre for Reviews and Dissemination, University of York, UK.

Health Technol Assess ; 11(2): iii-iv, xv-xviii, 1-179, 2007 Jan.

Article de En | MEDLINE | ID: mdl-17181985

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Prednisone / Modèles économiques / Taxoïdes / Glucocorticoïdes / Métastase tumorale / Antinéoplasiques Type d'étude: Clinical_trials / Health_economic_evaluation / Prognostic_studies / Systematic_reviews Aspects: Patient_preference Limites: Humans / Male Pays/Région comme sujet: Europa Langue: En Journal: Health Technol Assess Sujet du journal: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Année: 2007 Type de document: Article Pays d'affiliation: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links